PYXS – pyxis oncology, inc. (US:NASDAQ)
Stock Stats
News
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $7.00.
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201 [Yahoo! Finance]
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
CFO & COO of Pyxis Oncology Pamela Connealy Buys 13% More Shares [Yahoo! Finance]
Form SCHEDULE 13D/A Pyxis Oncology, Inc. Filed by: Sullivan Lara
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Sullivan Lara
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Connealy Pamela Ann
Form 4 Pyxis Oncology, Inc. For: Dec 23 Filed by: Wadhane Jitendra
Form 8-K Pyxis Oncology, Inc. For: Dec 19
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.